Sudarshan Pharma Industries discloses CFO resignation effective May 1, 2026 pursuant to SEBI Listing Regulations.
Sachin Mehta resigns as Chief Financial Officer but continues as Joint Managing Director of the company.
Disclosure includes required regulatory details and resignation letter, confirming no operational disruption from resignation.